This New Way Of Saved People With Prostate Cancer

This New Way Of Saved People With Prostate Cancer

The verdict of prostate cancer was like doomsday for the men. That means they must undergo surgery or radiotherapy. The thing is, two way out it is the gateway to a new trouble. Both are not without side effects. The most severe, can lead to infertile men.

But now, researchers are finding ways to minimize medical measures for patients with prostate cancer. The team originated from the United Kingdom and the United States. The way that they apply is named Prolaris. Through a test, it can be distinguished from men with prostate cancer is dangerous and not.

The test works by analyzing the genetic changes of the tumor. The patient is then given a score from-3 to + 3. Who gets a higher score, meaning that it has a more aggressive cancer cells. That's what prioritized for surgery or radiotherapy treatment.

During this time, the test is not able to examine it. As a result, 90 percent of the total sufferers of prostate cancer should be operated on.

Professor Jack Cuzik, a scientist at Cancer Research UK, based at Queen Mary University of London mentioned, too much treatment against prostate cancer is a serious problem. For that, it needs to be analyzed first sufferers are at a stage of cancer which.

"Patients with cancer that grows slower meaning more safe and not at risk if left. They did not need surgery and took away the side effects, "said Cuzik, as reported by the Daily Mail page.

Dr. Harpal Kumar, cancer researcher and Chairman of the National Cancer Research Institute approves it. According to him, understand the nature of cancer cells could be set aside thousands of unnecessary treatment and side effects it produces.

In the meantime, new Prolaris test can be done in a laboratory in Utah. People should send samples of kankernya to it. However, the researchers developed a central experiment further.

Moreover, each year there are 40 thousand new prostate cancer patients in the United Kingdom. The number of deaths is declining a fifth in the last 20 years. Cause, diagnosis and treatment is better. However, it does not mean that people are free from the side effects of prostate cancer.

Furthermore, the cost to perform tests on Prolaris only £ 17 thousand, or about Rp31 billion. That figure is far lower than the patient must undergo surgery or radiotherapy.